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Abstract The antigenic properties of a viral peptide from the
surface of foot-and-mouth disease virus particles have been
successfully mimicked by multiple insertion in solvent-exposed
regions of Escherichia coli L-galactosidase. By increasing the
number of viral peptides per enzyme monomer, the average IC50
of hybrid proteins in a competitive enzyme-linked immunosorbent
assay) have decreased to values close to that presented by natural
virions. Moreover, the antigenic diversity of these new recombi-
nant enzymes when measured with different anti-virus antibodies
has also been largely reduced, indicating a better presentation of
the epitopes located in the viral peptide. Although bivalent
antibody binding could have been favoured by multiple presenta-
tion, conformational modifications of the viral peptide, due to the
presence of other insertions or a cooperative antibody binding
cannot be excluded. In addition, a multidimensional antigenic
analysis have grouped together the multiple-inserted proteins
with the native virus, suggesting that increasing the number of
insertions could be a good strategy to reproduce the antigenic
properties of an immunoreactive peptide in a natural multimeric
disposition.
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1. Introduction
Small peptides reproducing continuous B-cell epitopes have
been widely used as antigens due to their simplicity and in-
nocuousness [1^4]. Although many of these peptides are rec-
ognised by monoclonal antibodies (MAb) elicited against the
native protein, in general this binding is somewhat less e⁄-
cient than where the peptide is placed in its natural location
[5]. This decrease in antibody binding can be attributed to
both the absence of large surface areas involved in anti-
body/antigen interaction [6^7] and the conformation adopted
by the peptide in solution or absorbed to a solid phase [3],
most often di¡erent to that presented in the protein. Several
approaches with di¡erent results have been taken to mimic the
structure of the peptide as in the intact protein, like cyclisa-
tion by a disulphide bridge or through lactam formation using
linkers of di¡erent length [8^9].
A major immunodominant region of foot-and-mouth dis-
ease virus (FMDV) serotype C1, also called site A, is located
in a hypervariable region of capsid protein VP1, which corre-
sponds to a segment of the G-H loop [10^11]. This viral
stretch, spanning residues 138 to 150, is composed of multiple,
continuous B-cell epitopes ([12] and references therein) and it
is involved in virus-cell attachment through an Arg-Gly-Asp
motif [13]. The VP1 G-H loop is an exposed, highly mobile,
disordered protrusion on the surface of virus particle, as de-
termined by X-ray crystallography of native virions [14^15].
This particular behaviour allows this segment to display mul-
tiple presentations to which several speci¢c antibodies could
be directed [16]. Linear synthetic peptides containing the site
A sequence have e¡ectively reproduced the reactivity and spe-
ci¢city of FMDV with neutralising monoclonal antibodies
[17^18]. Nevertheless, this binding is usually lower than in
the native virus, especially when used as free peptide in com-
petitive enzyme-linked immunosorbent assay (ELISA), owing
to its largely unstructured conformation. The cyclisation has
not improved the antigenicity of the peptide either [8]. To
better reproduce the characteristics of site A and its surround-
ing area, an interesting approach would be the insertion of the
viral sequence in a carrier protein, which would favour the
native peptide mobility and £exibility.
The Escherichia coli L-galactosidase protein is a well-known
molecular marker [19], because of its ability to hydrolyse lac-
tose analogues, like ortho-nitrophenyl-L-D-galactopyranoside,
chlorophenol red galactopyranoside or 5-bromo-4-chloro-3-
indolyl-L-D-galactopyranoside, rendering coloured compounds
that can be easily visualised in situ or spectrophotometrically
quanti¢ed [20]. This enzyme has also been used as a carrier
protein to stabilise heterologous proteins produced in bacteria
[21^22] and, more recently, several permissive sites have been
determined in exposed solvent regions of the protein [23^24].
Moreover, due to its tetrameric structure, four copies of the
heterologous domain are presented per molecule of hybrid
enzyme [25]. In previous work, we have analysed the antigen-
icity of a 23 amino acid peptide from FMDV VP1 protein
(residues 134^156), namely GH23, inserted at di¡erent sites on
the surface of L-galactosidase [26]. This study pointed out the
in£uence of the particular acceptor site in the reactivity with
antibodies, showing the importance of the molecular context
where the insertion has been made. However, the antigenic
reactivity of the inserted peptide was only similar to native
FMDV for some speci¢c antibodies and only in particular
insertion sites. To improve the antigenicity of recombinant,
peptide-based antigens we have constructed new hybrid pro-
teins with more than one insertion per monomer. In these
chimeras, the antigenic structure is much more similar to
that of the virus than that exhibited by single insertion pro-
teins. In addition, a greater antigenicity is observed in all the
analysed cases that cannot be attributed to a mere molar
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increase in the number of antibody binding sites, but to a
better reactivity between recombinant epitopes and monoclo-
nal antibodies.
2. Materials and methods
2.1. Vectors and plasmid construction
Plasmids pJLACZ, pM278VP1, pJX795A and pJX8CA are
pJLA602 derivatives that encode the E. coli L-galactosidase enzyme.
All of them, except the pseudo-wild type protein LACZ, encode a
segment of VP1 protein, named GH23 (residues 134^156), from
FMDV (isolate C-Sta. Pau, Spain/70, clone C-S8c1, serotype C [27])
inserted into di¡erent solvent-exposed loops of the enzyme [23^24].
In order to obtain new chimeras with more than one insertion of
the viral peptide per monomer (hybrid proteins) we used the SacI and
BsiWI restriction sites present in the lacZ gene. Speci¢cally,
pHD72CA was obtained by ligation of the 5.2 and 2.7 kb restriction
fragments from pJX8CA and pJX795A, respectively, digested at NcoI
and BsiWI restriction sites. For pHD78CA construction, the NcoI/
SacI fragment from pM278VP1 was inserted into pJX8CA after re-
moval of the 2 kb NcoI/SacI segment from this plasmid. For
pHD7278A, pM278VP1 and pJX795A were both digested at SacI
and EcoRI sites and the respective 6.8 and 1.1 kb fragments ligated.
Finally, to construct a hybrid protein with three copies of the viral
peptide, pHT7278CA, plasmids pM278VP1 and pHD72CA were cut
with NcoI and SacI and the respective 1.9 and 6 kb fragments ligated.
All of the engineered lacZ genes are under the control of the CI857ts-
repressed pR pL lambda promoters.
All of the constructs were transformed into E. coli K12 strain
MC1061, araD139, galE15, galK16, v(araA-leu)1697, v(codB-lacI)3,
hsdR2, mcrA, mcrB, relA1, rps150(strR), spoT1 [28], and the proteins
were produced in BL26 strain, a vlacZ derivative of BL21, dcm, gal,
hsdS, lon, ompT [29].
2.2. Production and puri¢cation of recombinant proteins
Bacterial cultures were grown in 200 ml of LB medium [30], plus
100 Wg/ml ampicillin and 50 Wg/ml streptomycin (when needed) in 1-l
shaker £asks, at 32‡C and 250 rpm. To induce the transcription of
recombinant genes, cell cultures were shifted to 42‡C when the OD
reached between 0.3 and 0.4 U, and incubated for further 4 h at
250 rpm. Cells were then harvested by centrifugation and sonicated
as previously described [31]. Puri¢cation of recombinant proteins was
done by a⁄nity chromatography with p-aminophenyl-L-D-thiogalacto-
side (TPEG)^Sepharose columns [32] and the puri¢ed protein dialysed
against Z bu¡er [20] without L-mercaptoethanol. The puri¢ed protein
concentration was determined spectrophotometrically at 280 nm, with
O= 1.5U105 M31 cm31 [24] or by polyacrylamide gel electrophoresis
followed by immunoblotting [26].
2.3. Enzymatic assay and determination of speci¢c activity
L-Galactosidase activity was determined according to Miller’s meth-
od [20] in a 1-ml reaction volume. One enzymatic unit is de¢ned as the
amount of protein that produces 1 Wmol o-nitrophenol per minute at
28‡C. The speci¢c activity was calculated from cell culture samples
with known enzymatic activity. The recombinant protein concentra-
tion was obtained by densitometric analysis of Western blot sheets,
using appropriate standards. Determinations were performed up to
three times for each protein.
2.4. Analysis of protein stability
All the analyses were done at 23 Wg/ml of protein, in Z bu¡er [20].
To determine the resistance to heat denaturation, the proteins were
incubated at di¡erent temperatures from 28 to 52‡C. Samples were
collected after 30 min, cooled at 4‡C and further incubated at 28‡C
for Miller’s assay [20]. Alternatively, the recombinant enzymes were
also incubated at 37‡C in the presence of 100 Wg/ml trypsin in Z
bu¡er. Aliquots were taken at di¡erent times and proteolysis was
immediately stopped by adding 10 WM soybean trypsin inhibitor.
Enzyme activity was determined as described above. Half-lives of
the active proteins under these conditions are given as t50. To analyse
the resistance to urea denaturation the proteins were incubated for 2 h
at 28‡C in Z bu¡er, in the presence of di¡erent concentrations of urea,
from 0 to 8 M. After a 10-fold dilution, the activity of each sample
was rapidly determined as described above. The urea concentration
that inactivated the 50% of protein initially present in the sample is
given as C50. All the determinations were done at least in triplicate.
2.5. Competitive ELISA
Competitive ELISA was performed as previously described [26].
Brie£y, 20 pmol GH23-KLH or 5 pmol puri¢ed LACZ protein
were incubated overnight in microtitre plates at 4‡C as coating anti-
gen. After saturating for 1 h with 3% (p/v) bovine serum albumin in
phosphate-bu¡ered saline (PBS), 100 Wl of the monoclonal antibodies
with puri¢ed recombinant proteins were added. These solutions con-
taining a non-saturating amount of monoclonal antibody were previ-
ously incubated for 1.5 h at room temperature with di¡erent concen-
trations of the proteins (competitive antigen). Plates were then
incubated for 1 h at room temperature, washed with PBS and further
incubated with 100 Wl of peroxidase-conjugated goat anti-mouse IgG
(Bio-Rad), followed by extensive washing. The amount of bound anti-
body was detected with 0.01% (p/v) H2O2, 0.8 mM 3-dimethylamino-
benzoic acid and 40 mM 3-methyl-2-benzotriazolinone in PBS bu¡er.
The reaction was stopped with 50 Wl of 2 N H2SO4. All the mono-
clonal antibodies used in this work were elicited against either wild-
type L-galactosidase (Roche) or against native FMDV, directed
against one of the multiple continuous epitopes within site A [33].
The IC50 value for each protein, de¢ned as the amount of compet-
itor antigen required to inhibit 50% of the binding of a particular
monoclonal antibody to the coating antigen, was calculated as de-
scribed elsewhere [34].
2.6. Clustering analysis
For cluster analysis, the IC50 value (in nM) obtained for each pro-
tein and mAb were used to compute an Euclidean distance matrix
between pairs of proteins. To identify putative clusters, a multidimen-
sional scaling was performed, as a ¢rst approach, with STATISTICA
4.5 for Windows. Then, several amalgamation methods were used for
hierarchical clustering (single and complete linkage, centroid, median,
weighted and unweighted pair-group average, Ward’s method), in
order to test consistency of the obtained clusters.
3. Results
3.1. Design and production of chimeric proteins
In previous work, we engineered several L-galactosidases
with a segment of FMDV VP1 protein fused or inserted at
di¡erent permissive sites on the enzyme surface [23^24]. To
further explore the tolerance of L-galactosidase to accommo-
date foreign peptides we have constructed new hybrid en-
zymes with more than one copy of the viral segment per
Table 1
Stability and enzymatic properties of recombinant proteins
Proteins Speci¢c activity (U/Wg) Urea stability (M) Thermal stability (‡C) Proteolytic stability (min)
LACZ 2765 þ 347 2.62 þ 0.005 50.8 þ 0.3 109.4 þ 10.2
M278VP1 170 þ 43 0.68 þ 0.008 45.3 þ 0.3 5.6 þ 0.1
JX795A 675 þ 102 1.99 þ 0.014 49.5 þ 0.3 22.1 þ 1.6
JX8CA 2840 þ 218 2.54 þ 0.002 50.7 þ 0.3 90.4 þ 5.4
HD78CA 99 þ 15 2.07 þ 0.014 44.1 þ 0.3 6.1 þ 0.7
HD72CA 385 þ 64 1.03 þ 0.021 46.8 þ 0.4 28.7 þ 3.7
HD7872A 8 þ 3 1.47 þ 0.052 47.9 þ 0.6 33.5 þ 6.3
HT7278CA 3 þ 4 0.54 þ 0.084 40.5 þ 2.3 1.6 þ 0.1
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monomer. For this purpose, we selected proteins with a low
antigenicity of the epitopes present in GH23 (Table 2), in an
attempt to improve it by increasing the number of insertions.
By using proteins M278VP1, JX795A and JX8CA we have
designed all the possible combinations of two and three in-
sertions. The new enzymes HD78CA, HD72CA and
HD7872A carry two copies at amino acid positions 278 and
C-terminus, 795 and C-terminus, and 278 and 795, respec-
tively, whereas HT7278CA presents three copies of GH23 at
positions 278, 795 and C-terminus (Fig. 1).
During production of these new recombinant proteins, no
inhibition of cell growth was detected and a very similar yield
was reached (not shown), indicating low toxicity of these en-
zymes and comparable turn over for all the proteins. An im-
portant feature of these chimeras is the maintenance of their
enzymatic activity even in the triple hybrid (Table 1), which
allows its e⁄cient puri¢cation with TPEG^Sepharose columns
(not shown).
The study of the speci¢c activity revealed important di¡er-
ences between the new enzymes and the respective parental
proteins with a single insertion (Table 1). This trait is espe-
cially dramatic in HD7872A and HT7278CA with an activity
of nearly 100-fold lower than M278VP1 or JX795A, and 1000
times lower than the C-terminal GH23 fusioned protein
JX8CA or the pseudo wild-type enzyme LACZ. Nevertheless,
these proteins can still be easily quanti¢ed and their produc-
tion monitored by the Miller’s colourimetric assay [20].
3.2. Structural stability of hybrid L-galactosidases
The stability of all new proteins was determined by their
resistance to denaturation against temperature, urea and pro-
teolysis in vitro (Table 1). In all the performed experiments,
an important decrease in the stability of these chimeras has
been observed, due to the presence of more than one insertion
per monomer. As expected, there is a direct e¡ect between the
number of insertions and denaturation, HT7278CA being the
most sensitive construct in all the parameters analysed. How-
ever, it is worthy to note the higher resistance to denaturation
by temperature and proteolysis of HD7872A as compared to
HD78CA or HD72CA, despite the presence of two foreign
insertions in this construction and the important decrease of
about 300-fold in the speci¢c activity of this enzyme compared
with LACZ (Table 1).
On the other hand, whereas M278VP1 is the most sensitive
enzyme among proteins with a single insertion, the double
hybrid chimeras with an insertion at this position (HD78CA
and HD7872A) are equal or more resistant to denaturation
than M278VP1, especially in the presence of urea or trypsin.
This unexpected result indicates a stabilisation of M278VP1
by the presence of an additional insertion.
3.3. Reactivity of chimeric proteins with site A-speci¢c MAbs
The antigenicity of engineered L-galactosidases was ana-
lysed in competitive ELISA by using di¡erent monoclonal
antibodies directed against FMDV site A. All the examined
enzymes were well recognised by MAbs, with slight di¡erences
between antibodies (Table 2). Only in the case of MAb SD6,
the binding was always lower than in the other MAbs, with
values of IC50 up to 10 times higher, depending on the anti-
body or the enzyme analysed.
The average IC50 has been calculated to estimate the overall
antigenicity of each protein in particular, but considering to-
gether all the MAbs used in this work (Table 2). This ap-
proach could be done because this set of MAbs is representa-
tive of a larger panel of neutralising MAbs which recognise
antigenic features of site A similar to those recognised by
antibodies of swine, a natural host for FMDV [26]. Thus,
despite JX8CA being a good antigen with an average IC50
similar to that of the peptide conjugated to KLH, the re-
combinant enzymes M278VP1 and JX795A are less reactive
to MAbs than GH23-KLH (Table 2). However, hybrid pro-
teins with multiple copies of the tested antigen show not only
Fig. 1. Top: Lineal schematic representation of the L-galactosidase sequence with the insertion sites indicated by black boxes. Bottom: Amino
acid sequence of the GH23 peptide from FMDV clone C-S8c1. In italics, the amino acids encoded by the BamHI restriction site and underlined
the major immunodominant region site A [12].
Table 2
Antigenic features of modi¢ed L-galactosidases
Proteins Monoclonal antibodies (nMa) Average IC50 (nMa) Variation coe⁄cient (%)
3E5 6D11 7FC12 7JD1 SD6
GH23-KLH 9.70b 11.77 92.12 12.65 62.10 37.7 100
M278VP1 69.00 66.00 298.00 267.00 218.00 183.6 60
JX795A 9.15 12.79 75.21 17.14 954.17 213.7 194
JX8CA 10.83 13.70 2.01 0.15 175.63 40.5 187
HD78CA 1.63 1.38 0.67 1.27 6.05 2.2 99
HD72CA 2.73 2.09 0.64 0.76 21.82 5.6 162
HD7872A 4.06 2.77 2.01 1.89 7.78 3.7 66
HT7278CA 3.17 6.33 1.83 1.96 4.41 3.5 53
FMDVc 2.70 10.50 3.50 2.50 15.00 6.8 82
aConcentration of competitive antigen.
bIC50 of synthetic peptide and recombinant proteins in competitive ELISA.
cFMDV stands for VP1 protein in FMDV particles, clone C-S8c1.
FEBS 23710 18-5-00
J.X. Feliu et al./FEBS Letters 474 (2000) 87^92 89
an important decrease in the average IC50 values in relation to
their parental proteins, suggesting a clear improvement in the
recognition by antibodies, but also a better binding to anti-
bodies than GH23-KLH and similar to FMDV particles. Fur-
thermore, the variation coe⁄cient value is lower in most of
the analysed hybrid enzymes than in parental ones (Table 2),
indicating a narrower deviation in the antibody recognition of
the epitopes of site A than when presented in single-inserted
proteins.
To better analyse the e¡ect of multiple peptide presentation
we have also examined the antigenic pro¢le of all the hybrid
enzymes in a multidimensional antigenic space generated by
the analysed epitopes (Fig. 2). By considering clusters below
100 nM, FMDV virions and hybrid proteins with several cop-
ies of the antigen are grouped together. On the other hand,
the viral peptide coupled to KLH appears in another cluster
with protein JX8CA, while enzymes M278VP1 and JX795A
with a single internal insertion of the peptide split from the
rest of the antigens by 700 and 1500 nM, respectively.
3.4. E¡ect of peptide insertions and MAb binding on
L-galactosidase immunoreactivity
To determine the e¡ect of the viral segment insertion on the
immunoreactivity of other enzyme regions, we explored if the
structural changes promoted by the inserted peptide could
modulate the binding of monoclonal antibodies against the
carrier protein. A competitive ELISA using a monoclonal
antibody against L-galactosidase and protein LACZ as com-
petitive antigen shows a signi¢cant improvement in the L-ga-
lactosidase epitope recognition of JX8CA and M278VP1,
when compared with enzyme LACZ (Table 3). Only in protein
JX795A does the presence of the viral peptide impair the anti-
body recognition of L-galactosidase, perhaps by steric hin-
drance.
To further investigate if the binding of an antibody can
modulate the coupling of a secondary antibody in a di¡erent
site, we examined in competitive ELISA the e¡ect of the pres-
ence of a site A-speci¢c MAb (SD6) on the binding of a MAb
directed against L-galactosidase. Even though the results ren-
der no signi¢cant data, there is a di¡erent tendency depending
on the protein studied (Table 3). Thus, while in mutant
JX795A and in the pseudo-wild type protein LACZ the pres-
ence of SD6 has no e¡ect in the recognition of L-galactosidase
by its speci¢c MAb, in the case of M278VP1 or JX8CA, the
pre-incubation with SD6 improves the binding of the MAb
anti L-galactosidase to the carrier protein.
4. Discussion
The L-galactosidase enzyme has been used as a carrier pro-
tein for many purposes [32,35^36]. Among them, one of the
most recent applications is the engineering of L-galactosidase
to be used as an epitope tagging for the detection of anti-
bodies [23^24]. To generate good antibody sensors and in
general recombinant ligands it is important to keep the reac-
tivity of the probe as similar as possible as in its natural
location. Up to now, only single insertions had been made
in L-galactosidase looking for particular sites that would re-
produce the epitope environment as in the original protein.
Unfortunately, the antigenicity achieved only reached levels
similar to those presented by FMDV for some speci¢c mono-
clonal antibody and depending on the insertion site [26]. An
alternative but still unexplored strategy to improve the anti-
genicity of an inserted epitope in this carrier protein would be
the increase of copies of the foreign peptide per molecule of
carrier protein.
L-Galactosidase protein can tolerate up to three copies of a
27-mer viral peptide at amino acid positions 278, 795 and
C-terminal, without loosing its activity (Table 1). However,
the results obtained with hybrid enzymes denote that the
structural changes promoted by the simultaneous presence
of more than one peptide per enzyme monomer have an un-
predictable outcome in the stability and activity of the new
recombinant proteins, as noticed by comparing proteins
HD78CA and HD7872A with their parental enzymes
M278VP1, JX795A and JX8CA. An interesting observation
is the increase in protein stability upon peptide insertion or
fusion at C-terminus besides the one at position 278 (Table 1).
This region of L-galactosidase, amino acids from 272 to 288,
is involved in the monomer^monomer contacts through a
protruding loop that extends across the activating interface
to the neighbouring monomer [37]. Insertions in this area
Fig. 2. Hierarchical clustering tree of the di¡erent recombinant pro-
teins obtained by Ward’s amalgamation method using Euclidean
distances.
Table 3
Statistical analysis of antibody binding by ANOVA tests
Protein Without MAb SD6 Pa With MAb SD6 Pb
LACZ 2.41c þ 0.22 ^ 2.47c þ 0.18 0.624
M278VP1 2.01 þ 0.05 0.0089 1.89 þ 0.15 0.372
JX8CA 1.78 þ 0.04 0.0006 1.57 þ 0.07 0.090
JX795A 2.82 þ 0.13 0.0087 2.85 þ 0.16 0.756
In bold face values with signi¢cance level below 0.01.
aDi¡erences between enzymes with the inserted viral peptide and the pseudo-wild type LACZ.
bDi¡erences between proteins pre-incubated with monoclonal antibody SD6 and without SD6.
cIC50 of native L-galactosidase and recombinant proteins in competitive ELISA.
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cause an important decrease in the enzymatic speci¢c activity
and also less resistance to denaturation [24]. Nevertheless, the
presence of a fusion at the C-terminus or a new insertion at
position 795, stabilise the recombinant enzyme, reaching val-
ues of relevant parameters close to those exhibited by the
chimera with either one single insertion at position 795 or a
fusion at the C-terminus. In the tetramer of L-galactosidase,
the position 795 from a monomer is very close to residue 278
from the monomer beside [37]. Owing to this proximity, the
conformational changes promoted by the presence of a for-
eign peptide at position 278 could be modi¢ed by a new in-
sertion at 795, improving the stability of the new protein when
compared with the enzyme with a single insertion. Yet, this
recovery has not been observed in the speci¢c activity (Table
1), probably because residue 794 of L-galactosidase is involved
in the catalytic function of the enzyme [38], and insertions
close to this position lead to a dramatic decrease in the cata-
lytic constant of the protein [24].
All the constructs used in this work contain the loop G-H
of VP1 protein from FMDV, spanning residues from 134 to
156 [14]. This peptide, named GH23, contains the major anti-
genic site of FMDV (site A), made up of several overlapping
B-cell epitopes [12,33]. The insertion of this segment on the
surface of L-galactosidase has improved its antigenicity in
relation to the peptide alone in solution or coupled to KLH
[26,39]. Moreover, by increasing the number of copies of
GH23 per monomer, the average IC50 has signi¢cantly de-
creased (Table 1), suggesting a better reactivity between anti-
bodies and epitopes. Despite having more determinants per
protein, the binding enhancement is not additive. Thus, this
improvement cannot only be attributed to an increase of the
binding sites per antibody, but to a greater a⁄nity.
The chance of a bivalent binding is clearly favoured in
hybrid proteins with two or three copies of the viral peptide
per monomer. However, it also has to be considered that the
conformational modi¢cations promoted by the presence of
several insertions in a same protein could either facilitate
the accessibility of the antibody to the epitope or lead to a
structure of the determinant which is best recognised by anti-
bodies than in proteins with a single insertion. In addition, the
stability and especially the activity of hybrid proteins have
been impaired when increasing the number of insertions, sug-
gesting important structural changes. The antigenicity analysis
of a L-galactosidase epitope showed signi¢cant di¡erences be-
tween proteins with the inserted viral peptide and the pseudo-
wild type protein LACZ (Table 3), indicating that the inser-
tional sites used in this work can alter the protein structure
enough to improve or impair the antibody binding in a di¡er-
ent place.
The binding of an antibody can induce both local confor-
mational changes in a protein or in the whole molecule, which
can even a¡ect its function [40^41]. Such a mechanism has
been broadly analysed in L-galactosidase where a series of
inactive mutants can be restored in their activity upon inter-
action with monoclonal antibodies [42]. More recently, it has
been proven that low active recombinant L-galactosidases
with a 27-mer foreign peptide inserted near the active site,
can be modulated by antibodies directed against the peptide
inserted [43]. It has been previously described that in proteins
with multiple determinants, the antibody binding may be co-
operative between antibody pairs that recognise di¡erent epi-
topes [44], probably by conformational changes promoted by
the attachment of the ¢rst antibody. The same mechanism has
also been noticed in multivalent proteins using di¡erent
monoclonal antibodies [45]. In the case of single-insertion
L-galactosidase proteins we have not observed signi¢cant dif-
ferences in the recognition of a MAb directed against the
carrier protein between enzymes that have been previously
incubated or not with a MAb against the viral peptide (Table
3). Nevertheless, the binding of an antibody to the foreign
peptide can modulate the enzyme activity at least in proteins
JX795A and M278VP1 [43,46]). This suggests that antibodies
are able to promote conformational changes but these mod-
i¢cations are not su⁄cient to improve the recognition of an-
other epitope in single-inserted proteins.
In a previous study, we examined the antigenic pro¢le of
site A inserted at di¡erent positions of two carrier proteins
and compared it with this peptide coupled to KLH or with
native FMDV [34]. In this former investigation, proteins
M278VP1, JX795A and JX8CA were in distinct groups, in-
dicating a di¡erent antigenic behaviour, and JX8CA only ap-
peared in the same cluster as FMDV. Now, by increasing the
number of antibody binding sites, the variability in the recog-
nition of the epitopes by all the MAbs decreases in the hybrid
proteins, down to values similar to that presented by FMDV
particles. This result suggests a better presentation of the anti-
genic region located in the inserted segment and consequently,
an antigenic convergence of the whole recombinant antigen
with FMDV (Table 2 and Fig. 2).
The G-H loop from FMDV is a highly mobile, disordered
protrusion that could display multiple presentations through
hinge movements [14^15]. The fact that a G-H loop contain-
ing recombinant protein is only well recognised by some spe-
ci¢c antibodies could be due to a restriction of the £exibility
of this peptide by selective insertion in L-galactosidase [26,39].
However, hybrid proteins with several insertions are more
unstructured than enzymes with single insertions, as observed
in their stability and speci¢c activity (Table 1). This situation
could allow the viral peptide to be more exposed or even more
£exible as in the capsid of virus, thus mimicking the anti-
genicity of FMDV site A.
The usual procedure of obtaining peptide-displaying re-
combinant antigens is to look for permissive sites in the car-
rier protein that would reproduce not only the determinant
structure but also its environment. Despite the fact of being a
good strategy, the limitation of permissive sites in a protein
and the di⁄culties in ¢nding them makes this approach tedi-
ous and uncertain. In addition, for L-galactosidase, the high
values obtained in the variation coe⁄cient with single-inserted
recombinant enzymes (Table 2) indicate that we have only
partially reproduced the characteristics of the epitopes. An
alternative method of improving the antigenicity of the viral
epitopes, as demonstrated in this work, would be to increase
the peptide copy number per enzyme, once we know some
tolerant acceptor sites. In this way, we have obtained chimeric
L-galactosidases that successfully have mimicked the anti-
genicity site A capsid protein VP1 in the FMDV.
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